MREO
Mereo Biopharma·NASDAQ
--
--(--)
--
--(--)
MREO fundamentals
Mereo Biopharma (MREO) released its earnings on Nov 10, 2025: revenue was 300.00K (YoY --), missed estimates; EPS was -0.01 (YoY +50.00%), missed estimates.
Revenue / YoY
300.00K
--
EPS / YoY
-0.01
+50.00%
Report date
Nov 10, 2025
EPS
Actual | -0.02 | -0.01 | -0.02 | -0.02 | -0.01 | ||||||
Forecast | -0.01 | -0.0129 | -0.0071 | -0.0117 | -0.0057 | ||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | +22.48% | -181.69% | -70.94% | -75.44% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 500.00K | 300.00K |
Forecast | -- | -- | -- | -- | -- | -- | 0 | 36.25M | 26.88M | 0 | 11.67M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -100.00% | 0.00% | -97.43% |
Earnings Call
You can ask Aime
What factors drove the changes in Mereo Biopharma's revenue and profit?Did Mereo Biopharma beat or miss consensus estimates last quarter?What guidance did Mereo Biopharma's management provide for the next earnings period?What were the key takeaways from Mereo Biopharma's earnings call?What does Mereo Biopharma do and what are its main business segments?What were the key takeaways from Mereo Biopharma’s earnings call?What is the market's earnings forecast for Mereo Biopharma next quarter?What is Mereo Biopharma's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
